Startup in the Seattle area Truveta released a first version of its healthcare data platform and signed three new partners for its healthcare provider system. The total funding raised by Truveta also reached nearly $ 200 million, the company announced Tuesday.
The new money follows a $ 95 million Series A round grown up in July by members of its healthcare system and an undisclosed investment by Microsoft unveiled in September as part of a partnership to build Truveta’s platform on the tech giant’s Azure cloud platform.
Truveta emerged in 2020 with an ambitious vision: to aggregate data across multiple health systems to provide medical insights.
The company “was born from the experience in the pandemic that we do not have the data we needed to know how to take care of our patients, to know which therapies have worked well”, the CEO Terry Myerson he said in an interview with GeekWire. Myerson is a former Microsoft executive who headed the company’s Windows and Devices Group before leaving in 2018 after a 21-year career at the tech giant.
At the start of the pandemic, “doctors were really grabbing straws for patient data. What are the different medical diagnoses that bring people to the hospital?” She said Michael Simonov, director of clinical informatics at Truveta who has treated COVID-19 patients as a practicing physician for the Veterans Administration in Connecticut. He is also a lecturer in health informatics at Yale University.
The company now has more than 100 employees and has signed 20 health system members with new partners. It has access to the data of over 35 million people, which represents 16% of health care in the United States
The new health systems are Ochsner Health in Louisiana, Saint Luke’s Health System in Kansas, and West Des Moines, Iowa-based UnityPoint Health.
The company has begun to de-identify and aggregate health data, with a focus on COVID-19. In an interview with GeekWire e in a video, Myerson presented a dashboard tapping into individuals within its partner health systems.
For example, the data provides information on COVID-19 vaccinated patients who have breakthrough infections. For each question, the system will provide data only on patients whose data has been anonymized and is ready for analysis.
The company released a first analysis of approximately 1.7 million fully vaccinated patients, showing that patients with certain chronic conditions are more likely to be hospitalized after a groundbreaking diagnosis of COVID-19 than the general population. People with diabetes, chronic lung disease, or chronic kidney disease were nearly twice as likely to be hospitalized, in line with findings from other studies.
“We have the ability to be very transparent about how each population was defined and how each parameter within that population was defined,” Myerson said, adding that data such as age, ethnicity and other conditions are readily available.
The first analysis has limitations. For example, it does not specify whether people were hospitalized specifically for COVID-19. But the researchers aim to dig deeper into the data in the future and expand to new questions about health care.
“There will be more questions and more answers and iterations, and just continuous improvement,” Myerson said.
The new findings show the potential power of Truveta’s large dataset.
The data is available to health researchers within the company’s partner institutions. These include Providence, the largest health care system based in the state of Washington. Providence what? involved in the formation of the company and has fostered growth startup collection, such as digital health services company Xealth.
External researchers are encouraged to contact Truveta for access to its platform as well, the company said. Health data is required by medical service providers as well as pharmaceutical companies and academic researchers developing new tools and treatments. Linking treatments with outcomes and underlying health can allow researchers to better understand the effectiveness of health interventions.